-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Lipoprotein(a) (Lp(a)) contributes to cardiovascular disease mainly through pro-atherosclerotic and pro-inflammatory effects
vascular cholesterol stroke
This prospective cohort study included 9899 patients with ischemic stroke or transient ischemic attack from a third national stroke registry in China, and measured plasma Lp(a) in the subjects and followed up for 1 year
Cholesterol-corrected LDL-C (LDL-Cc [LDL-C-corrected]) was obtained from Lp(a), with cutoff values of 55 and 70 mg/dL
Among all patients, those with Lp(a) ≥50 mg/dL had a higher risk of recurrent stroke than those with Lp(a) <50 mg/dL (11.
CONCLUSIONS: In patients with ischemic stroke/transient ischemic attack, elevated Lp(a) levels were significantly associated with the risk of recurrent stroke
In patients with ischemic stroke/transient ischemic attack, elevated Lp(a) levels were significantly associated with the risk of recurrent stroke
Original source:
Jie Xu.
Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels
Leave a Comment here